TP53 and cancer: Oncogenic mutations in TP53 have been shown in different cancer cell lines which may involve invasion, migration, propagation of cell cycle, drug resistance, anchorage-independent growth, increased colony formation, polyploidy and angiogenesis (Effert et al., 1992; Muller and Vousden, 2014).